148 related articles for article (PubMed ID: 34316386)
1. Explanatory Analysis of a Machine Learning Model to Identify Hypertrophic Cardiomyopathy Patients from EHR Using Diagnostic Codes.
Farahani NZ; Arunachalam SP; Sundaram DSB; Pasupathy K; Enayati M; Arruda-Olson AM
Proceedings (IEEE Int Conf Bioinformatics Biomed); 2020 Dec; 2020():1932-1937. PubMed ID: 34316386
[TBL] [Abstract][Full Text] [Related]
2. NATURAL LANGUAGE PROCESSING BASED MACHINE LEARNING MODEL USING CARDIAC MRI REPORTS TO IDENTIFY HYPERTROPHIC CARDIOMYOPATHY PATIENTS.
Sundaram DSB; Arunachalam SP; Damani DN; Farahani NZ; Enayati M; Pasupathy KS; Arruda-Olson AM
Proc Des Med Devices Conf; 2021 Apr; 2021():. PubMed ID: 35463194
[TBL] [Abstract][Full Text] [Related]
3. Automated extraction of sudden cardiac death risk factors in hypertrophic cardiomyopathy patients by natural language processing.
Moon S; Liu S; Scott CG; Samudrala S; Abidian MM; Geske JB; Noseworthy PA; Shellum JL; Chaudhry R; Ommen SR; Nishimura RA; Liu H; Arruda-Olson AM
Int J Med Inform; 2019 Aug; 128():32-38. PubMed ID: 31160009
[TBL] [Abstract][Full Text] [Related]
4. Automated feature selection of predictors in electronic medical records data.
Gronsbell J; Minnier J; Yu S; Liao K; Cai T
Biometrics; 2019 Mar; 75(1):268-277. PubMed ID: 30353541
[TBL] [Abstract][Full Text] [Related]
5. Deep learning algorithm to improve hypertrophic cardiomyopathy mutation prediction using cardiac cine images.
Zhou H; Li L; Liu Z; Zhao K; Chen X; Lu M; Yin G; Song L; Zhao S; Zheng H; Tian J
Eur Radiol; 2021 Jun; 31(6):3931-3940. PubMed ID: 33241513
[TBL] [Abstract][Full Text] [Related]
6. ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.
Hinojar R; Zamorano JL; Gonzalez Gómez A; Plaza Martin M; Esteban A; Rincón LM; Portugal JC; Jimenez Nácher JJ; Fernández-Golfín C
Clin Cardiol; 2017 Oct; 40(10):853-860. PubMed ID: 28614597
[TBL] [Abstract][Full Text] [Related]
7. Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model).
Bhattacharya M; Lu DY; Kudchadkar SM; Greenland GV; Lingamaneni P; Corona-Villalobos CP; Guan Y; Marine JE; Olgin JE; Zimmerman S; Abraham TP; Shatkay H; Abraham MR
Am J Cardiol; 2019 May; 123(10):1681-1689. PubMed ID: 30952382
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Genotype Positivity in Patients With Hypertrophic Cardiomyopathy Using Machine Learning.
Liang LW; Fifer MA; Hasegawa K; Maurer MS; Reilly MP; Shimada YJ
Circ Genom Precis Med; 2021 Jun; 14(3):e003259. PubMed ID: 33890823
[TBL] [Abstract][Full Text] [Related]
9. Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.
Weissler-Snir A; Allan K; Cunningham K; Connelly KA; Lee DS; Spears DA; Rakowski H; Dorian P
Circulation; 2019 Nov; 140(21):1706-1716. PubMed ID: 31630535
[TBL] [Abstract][Full Text] [Related]
10. Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning.
Kochav SM; Raita Y; Fifer MA; Takayama H; Ginns J; Maurer MS; Reilly MP; Hasegawa K; Shimada YJ
Int J Cardiol; 2021 Mar; 327():117-124. PubMed ID: 33181159
[TBL] [Abstract][Full Text] [Related]
11. Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical Care.
Captur G; Manisty CH; Raman B; Marchi A; Wong TC; Ariga R; Bhuva A; Ormondroyd E; Lobascio I; Camaioni C; Loizos S; Bonsu-Ofori J; Turer A; Zaha VG; Augutsto JB; Davies RH; Taylor AJ; Nasis A; Al-Mallah MH; Valentin S; Perez de Arenaza D; Patel V; Westwood M; Petersen SE; Li C; Tang L; Nakamori S; Nezafat R; Kwong RY; Ho CY; Fraser AG; Watkins H; Elliott PM; Neubauer S; Lloyd G; Olivotto I; Nihoyannopoulos P; Moon JC
JACC Cardiovasc Imaging; 2021 Nov; 14(11):2123-2134. PubMed ID: 34147459
[TBL] [Abstract][Full Text] [Related]
12. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
[No Abstract] [Full Text] [Related]
13. Artificial intelligence approaches for phenotyping heart failure in U.S. Veterans Health Administration electronic health record.
Shao Y; Zhang S; Raman VK; Patel SS; Cheng Y; Parulkar A; Lam PH; Moore H; Sheriff HM; Fonarow GC; Heidenreich PA; Wu WC; Ahmed A; Zeng-Treitler Q
ESC Heart Fail; 2024 Jun; ():. PubMed ID: 38873749
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.
Kamal MU; Riaz IB; Janardhanan R
Cardiol J; 2016; 23(3):250-63. PubMed ID: 27064795
[TBL] [Abstract][Full Text] [Related]
15. Texture analysis and machine learning of non-contrast T1-weighted MR images in patients with hypertrophic cardiomyopathy-Preliminary results.
Baeßler B; Mannil M; Maintz D; Alkadhi H; Manka R
Eur J Radiol; 2018 May; 102():61-67. PubMed ID: 29685546
[TBL] [Abstract][Full Text] [Related]
16. Identification of Hypertrophic Cardiomyopathy on Electrocardiographic Images with Deep Learning.
Sangha V; Dhingra LS; Oikonomou E; Aminorroaya A; Sikand NV; Sen S; Krumholz HM; Khera R
medRxiv; 2023 Dec; ():. PubMed ID: 38234746
[TBL] [Abstract][Full Text] [Related]
17. Automatic machine learning based on native T1 mapping can identify myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Peng WL; Zhang TJ; Shi K; Li HX; Li Y; He S; Li C; Xia D; Xia CC; Li ZL
Eur Radiol; 2022 Feb; 32(2):1044-1053. PubMed ID: 34477909
[TBL] [Abstract][Full Text] [Related]
18. A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy.
Smole T; Žunkovič B; Pičulin M; Kokalj E; Robnik-Šikonja M; Kukar M; Fotiadis DI; Pezoulas VC; Tachos NS; Barlocco F; Mazzarotto F; Popović D; Maier L; Velicki L; MacGowan GA; Olivotto I; Filipović N; Jakovljević DG; Bosnić Z
Comput Biol Med; 2021 Aug; 135():104648. PubMed ID: 34280775
[TBL] [Abstract][Full Text] [Related]
19. Impact of cardiac magnetic resonance on the diagnosis of hypertrophic cardiomyopathy - a 10-year experience with over 1000 patients.
Śpiewak M; Kłopotowski M; Ojrzyńska N; Petryka-Mazurkiewicz J; Miłosz-Wieczorek B; Mazurkiewicz Ł; Grzybowski J; Bilińska Z; Witkowski A; Marczak M
Eur Radiol; 2021 Mar; 31(3):1194-1205. PubMed ID: 32876838
[TBL] [Abstract][Full Text] [Related]
20. Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study.
Lyon A; Mincholé A; Bueno-Orovio A; Rodriguez B
Morphologie; 2019 Dec; 103(343):169-179. PubMed ID: 31570308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
